No details about pricing have been released by Sandoz yet, though it priced its first US biosimilar Zarxio at 15% discount to the originator drug Neupogen, another Amgen drug. Sandoz gave no ...

Biosimilars are essential healthcare equalizers, but their regulation is overly complicated due to lobbying by makers of ...

The first ever US-approved biosimilar approved is Zarxio, Sandoz's version of Amgen's Neupogen (filgrastim) white blood cell stimulator. However it has captured only around 7% of the market ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...